Venlafaxine tablets, XL capsules
Depressive illness, generalised anxiety disorder (XL formulation only)
Central nervous system
LSCMMG is adopting the local decision made prior to April 2013.
The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.
Reason for decision:
Suitable for initiation in primary care